MSE
ABBV icon

MUFG Securities EMEA’s AbbVie ABBV Stock Holding History

MUFG Securities EMEA’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94.1M Buy
432,445
+360,000
+497% +$79.9M 1.4% 18
2025
Q4 		$16.6M Buy
72,445
+38,632
+114% +$8.8M 0.19% 96
2025
Q3 		$7.83M Buy
33,813
+28,593
+548% +$5.82M 0.2% 86
2025
Q2 		$969K Buy
+5,220
New +$970K 0.04% 107
2024
Q3 		– Sell
-149,999
Closed -$25.7M – 155
2024
Q2 		$25.7M Buy
+149,999
New +$24.8M 1.1% 22
2024
Q1 		– Sell
-140,000
Closed -$21.7M – 74
2023
Q4 		$21.7M Buy
+140,000
New +$20.4M 1.28% 25
2023
Q3 		– Sell
-148,665
Closed -$20M – 105
2023
Q2 		$20M Buy
+148,665
New +$21.8M 0.13% 32
2022
Q2 		– Sell
-92
Closed -$15K – 126
2022
Q1 		$15K Sell
92
-710
-89% -$103K ﹤0.01% 149
2021
Q4 		$109K Sell
802
-244,998
-100% -$28.9M ﹤0.01% 163
2021
Q3 		$26.5M Sell
245,800
-239,500
-49% -$27.4M 0.3% 52
2021
Q2 		$54.7M Buy
485,300
+244,121
+101% +$27.5M 0.52% 42
2021
Q1 		$26.1M Sell
241,179
-303,821
-56% -$32.5M 0.21% 93
2020
Q4 		$58.4M Buy
545,000
+350,556
+180% +$33.7M 0.44% 38
2020
Q3 		$17M Sell
194,444
-301,600
-61% -$28.4M 0.16% 101
2020
Q2 		$48.7M Buy
+496,044
New +$43.7M 0.42% 46
2019
Q3 		– Sell
-382,899
Closed -$27.8M – 329
2019
Q2 		$27.8M Buy
382,899
+82,899
+28% +$6.52M 0.29% 63
2019
Q1 		$24.2M Buy
300,000
+245,000
+445% +$20M 0.28% 76
2018
Q4 		$5.07M Sell
55,000
-69,051
-56% -$6.07M 0.05% 173
2018
Q3 		$11.7M Buy
124,051
+122,353
+7,206% +$11.6M 0.17% 95
2018
Q2 		$157K Buy
+1,698
New +$166K ﹤0.01% 254
2018
Q1 		– Sell
-300,000
Closed -$29M – 195
2017
Q4 		$29M Buy
+300,000
New +$28.3M 0.67% 34
2015
Q3 		– Sell
-30,000
Closed -$2.02M – 99
2015
Q2 		$2.02M Buy
+30,000
New +$1.96M 0.33% 55

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MUFG Securities EMEA's ABBV Position: Q1 2026 in Review

MUFG Securities EMEA increased its AbbVie (ABBV) stake by 497% in Q1 2026, buying an estimated $79.9M and bringing the position to 432,445 shares worth $94.1M. The position accounts for 1.4% of the portfolio, ranked #18.

MUFG Securities EMEA first reported a position in ABBV in Q2 2015 and has held it in 22 quarters since. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • MUFG Securities EMEA held 432,445 shares of AbbVie worth $94.1M as of Q1 2026.
  • MUFG Securities EMEA bought 360,000 AbbVie shares in Q1 2026, an estimated $79.9M.
  • AbbVie made up 1.4% of MUFG Securities EMEA's portfolio in Q1 2026, its #18 holding.
  • MUFG Securities EMEA first reported a position in AbbVie in Q2 2015 and has held it in 22 quarters since.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on MUFG Securities EMEA's 13F filing for Q1 2026, filed 11 May 2026.